Literature DB >> 16490143

Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.

K H Dyet1, D R Martin.   

Abstract

An epidemic of meningococcal disease caused by serogroup B meningococci expressing the P1.7-2,4 PorA protein began in New Zealand in 1991. The PorA type has remained stable. Different porB have been found in association with the P1.7-2,4 PorA, although type 4 has been most common. The clonal origins of B:P1.7-2,4 meningococci isolated from cases during 1990 to the end of 2003 were analysed. In 1990, the year immediately preceding the recognized increase in disease rates, all three subclones (ST-41, ST-42, and ST-154) of the ST-41/44 clonal complex occurred among the five isolates of B:P1.7-2,4. The two sequence types, ST-42 and ST-154, continued to cause most disease throughout New Zealand. Isolates belonging to subclone ST-41 were mostly identified early in the epidemic and in the South Island. 16S rRNA typing indicated that isolates belonging to the subclones ST-41 and ST-154 share a common ancestor, with those typing as ST-42 more distantly related with some genetically ambiguous. It is possible that ST-41 and ST-154 may have evolved one from the other but evolution to ST-42 is more difficult to explain. It is possible that one or more of the ST types could have been introduced into New Zealand prior to the first detection of clinical cases in 1990. Genetic diversity may have occurred during carriage in the community.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490143      PMCID: PMC2870387          DOI: 10.1017/S0950268805004954

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  28 in total

1.  Evaluation of porB PCR-amplicon restriction endonuclease analysis as a method to determine porB variable-region sequences in nonserotypeable meningococci.

Authors:  Kristin H Dyet; Robin S Simmonds; Diana R Martin
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Multilocus restriction typing method to predict the sequence type of meningococci.

Authors:  Kristin H Dyet; Robin S Simmonds; Diana R Martin
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 3.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

4.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile.

Authors:  C Cruz; G Pavez; E Aguilar; L Grawe; J Cam; F Mendez; J Garcia; S Ruiz; P Vicent; I Canepa
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

6.  Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986.

Authors:  D A Caugant; P Bol; E A Høiby; H C Zanen; L O Frøholm
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

7.  Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.

Authors:  H Abdillahi; J T Poolman
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

8.  Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.

Authors:  H Tettelin; N J Saunders; J Heidelberg; A C Jeffries; K E Nelson; J A Eisen; K A Ketchum; D W Hood; J F Peden; R J Dodson; W C Nelson; M L Gwinn; R DeBoy; J D Peterson; E K Hickey; D H Haft; S L Salzberg; O White; R D Fleischmann; B A Dougherty; T Mason; A Ciecko; D S Parksey; E Blair; H Cittone; E B Clark; M D Cotton; T R Utterback; H Khouri; H Qin; J Vamathevan; J Gill; V Scarlato; V Masignani; M Pizza; G Grandi; L Sun; H O Smith; C M Fraser; E R Moxon; R Rappuoli; J C Venter
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

9.  New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.

Authors:  K Dyet; A Devoy; R McDowell; D Martin
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

10.  Paenibacillus turicensis sp. nov., a novel bacterium harbouring heterogeneities between 16S rRNA genes.

Authors:  Philipp P Bosshard; Reinhard Zbinden; Martin Altwegg
Journal:  Int J Syst Evol Microbiol       Date:  2002-11       Impact factor: 2.747

View more
  17 in total

1.  Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.

Authors:  E Wedege; K Bolstad; A Aase; T K Herstad; L McCallum; E Rosenqvist; P Oster; D Martin
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

2.  Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.

Authors:  Chivonne Moodley; Mignon du Plessis; Kedibone Ndlangisa; Linda de Gouveia; Keith P Klugman; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

3.  The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.

Authors:  D R Martin; N Ruijne; L McCallum; J O'Hallahan; P Oster
Journal:  Clin Vaccine Immunol       Date:  2006-04

4.  Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.

Authors:  Lee H Harrison; Kathleen A Shutt; Susanna E Schmink; Jane W Marsh; Brian H Harcourt; Xin Wang; Anne M Whitney; David S Stephens; Amanda A Cohn; Nancy E Messonnier; Leonard W Mayer
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

Review 5.  The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology.

Authors:  Vanessa N Racloz; Silva J D Luiz
Journal:  BMC Infect Dis       Date:  2010-06-17       Impact factor: 3.090

6.  Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.

Authors:  J S Plested; D M Granoff
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

7.  Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.

Authors:  Peter T Beernink; Dan M Granoff
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

8.  Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.

Authors:  Yanet Climent; Daniel Yero; Isabel Martinez; Alejandro Martín; Keith A Jolley; Franklin Sotolongo; Martin C J Maiden; Rachel Urwin; Rolando Pajón
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

9.  Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.

Authors:  Joyce S Plested; Jo Anne Welsch; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2009-04-01

10.  An expanded age range for meningococcal meningitis: molecular diagnostic evidence from population-based surveillance in Asia.

Authors:  Soon Ae Kim; Dong Wook Kim; Bai Qing Dong; Jung Soo Kim; Dang Duc Anh; Paul E Kilgore
Journal:  BMC Infect Dis       Date:  2012-11-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.